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Abstract
This is the sixth yearly article in the Tourette Syndrome Research
Highlights series, summarizing research from 2019 relevant to
Tourette syndrome and other tic disorders. The highlights from 2020
is being drafted on the Authorea online authoring platform; readers
are encouraged to add references or give feedback on our selections
comments feature on this page. After the calendar year ends, this
article is submitted as the annual update for the Tics collection
F1000Research.
Keywords
Tics, Tourette syndrome, 2019

Invited Reviewers
1

2

report

report

version 2
(revision)
04 Dec 2020

version 1
11 Nov 2020

report

1. Natalia Szejko

, Medical University of

Warsaw, Warsaw, Poland
Yale University, New Haven, USA

This article is included in the Tics collection.

2. Tammy Hedderly

, Evelina Children's

Hospital, London, UK
GSTT/KCL, London, UK
Any reports and responses or comments on the
article can be found at the end of the article.

Page 1 of 11

F1000Research 2020, 9:1314 Last updated: 13 JAN 2021

Corresponding author: Andreas Hartmann (andreas.hartmann@aphp.fr)
Author roles: Hartmann A: Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing; Worbe Y:
Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing; Black KJ: Conceptualization, Writing – Original Draft
Preparation, Writing – Review & Editing
Competing interests: KJB participated in a clinical trial supported by Emalex Biosciences. AH has received consultation fees from
Lundbeck and Noema Pharma.
Grant information: This work was supported in part by the U.S. National Institutes of Health (NIH), grant R01 MH104030.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Copyright: © 2020 Hartmann A et al. This is an open access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to cite this article: Hartmann A, Worbe Y and Black KJ. Tourette syndrome research highlights from 2019 [version 2; peer
review: 2 approved] F1000Research 2020, 9:1314 https://doi.org/10.12688/f1000research.27374.2
First published: 11 Nov 2020, 9:1314 https://doi.org/10.12688/f1000research.27374.1

Page 2 of 11

F1000Research 2020, 9:1314 Last updated: 13 JAN 2021

REVISED Amendments from Version 1
We thank the reviewer for their appreciation of our work. As
requested, we have expanded on the paper regarding TBI and
TS. References 1 and 17 were reformatted so as to begin with
the author’s name.
Any further responses from the reviewers can be found at
the end of the article

Introduction

This article is meant to disseminate recent scientific progress on
Gilles de la Tourette Syndrome (TS).

Methods

We searched PubMed from time to time during 2019 using the
search strategy “(”Tic Disorders“[MeSH] OR Tourette NOT
Tourette[AU]) AND 2019[PDAT] NOT 1950:2018[PDAT]”.
Colleagues also recommended articles, and we attended selected
medical conferences. We selected material for this review
subjectively, guided by our judgment of possible future impact
on the field.

Results
Phenomenology and natural history

Müller-Vahl et al.1 present a stimulating argument based on
data that demonstrate a severity continuum between chronic
tics and TS using a database regrouping 1018 subjects. They
thus conclude that TS and chronic tics do not represent distinct
diagnostic categories. Accordingly, they suggest the introduction of the the term “tic spectrum disorders” (in analogy to
autism spectrum disorders, ASDs) which might present the added
benefit of decreased social stigma related to TS.
Martino and Hedderly provide an excellent review on the
differences between tics and stereotypies, and their clinical
management2
A useful resource is the video atlas of various vocalizations
that includes tics and helps with differential diagnosis3.
Epidemiology. Several good epidemiological studies and
meta-analyses on the childhood prevalence of TS have been
published over the past years, with most figures ranging
between 0.5 to 0.8%, but they could be much higher. However,
prevalence in adulthood remains unknown. Levine et al.
analysed three studies (published 1986, 2011 and 2016) involving
2,356,485 participants4. Overall prevalence of TS in adulthood
was estimated to be 118 cases of TS per million adults, that
is 0.0118%. This appears very low, even factoring in remission
in two thirds to three quarters of childhood cases during
adulthood (which, in itself, is debatable). Clearly, more research
is needed on this important topic, preferably using current
DSM-5 criteria.
Tic suppression. Forty-five children with tics starting on
average only 3–4 months ago were assessed with clinical and
psychological methods and reassessed at the 12-month

anniversary of their first tic5. Children who were less able at
the first visit to suppress tics while given immediate rewards for
10-second tic-free intervals had worse clinical status (higher
YGTSS total tic score) at the follow-up visit six to nine
months later. This finding adds to the meager prognostic clues
available for Provisional Tic Disorder a simple, clinically
relevant test.
Sensory phenomena and premonitory urges. Rae and colleagues
provide a very thoroughly discussed computational model of
how tics and premonitory sensations may be generated6. The
model links premonitory phenomena and tics to a hypothesized
overly precise internal estimate of sensory information and
predicted movement, and has the key advantage of generating
some testable hypotheses.
Other. David Mataix-Cols’ group continue their epidemiological exploration of patients with TS and chronic tic disorders (CTD) using the Swedish National Patient Register.
This time, they looked for metabolic and cardiovascular
disorders in these patients and find that the risk is doubled
compared to the general population, especially with regard
to obesity, type 2 diabetes and circulatory system diseases.
With regard to co-morbidities, the presence of attention-deficit/
hyperactivity disorder (ADHD) significantly increased the
risk (however, excluding ADHD does not normalize the risk,
still 50% higher than in the general population). Most surprisingly, use of antipsychotic medication for more than
one year was associated with a significantly decreased risk
for metabolic and cardiovascular disorders in patients with
TS or CTD. This counterintuitive finding, given antipsychotics’
propensity to induce metabolic syndrome, requires further
clarification. For now, the authors speculate that patients with
TS or CTD receiving medication benefit from frequent follow
ups and better monitoring of their general health. In any case,
this is a further demonstration, after papers on suicide and
educational attainment in patients with TS or CTD, that
chronic tic disorders are far from benign and require correct
diagnosis, then regular care and follow up7.

Etiology
Genetics. 2019 has seen the publication of a variety of studies
using whole exome sequencing. Depienne et al.8 investigated
120 TS patients and identified disrupting variants of OPRK1,
encoding the opioid kappa receptor, in a significant subset of
subjects compared to controls. This result points to a role,
discussed since the 1980s, of the opioid system as involved in
the pathophysiology of TS and also suggest a new potential
therapeutic target.
After whole exome sequencing of 100 trios (TS patients and
their parents), point mutations in ASH1 Like Histone Lysine
Methyltransferase (ASH1L) causing defects in its enzymatic
activity were identified as a susceptibility gene for TS9,
previously associated with mental retardation and autism. A
transgenic mouse line (Ash1l heterozygous mice) indeed
displayed tic-like motor and compulsive behaviors, and dopaminergic hyperinnervation was observed in the dorsal striatum,
demonstrating good construct validity for this model.
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Two more genes, chromodomain helicase DNA binding
protein 8 (CHD8) and Signal Peptide, CUB Domain And EGF
Like Domain Containing 1 (SCUBE1), were identified by whole
exome sequencing in a cohort of 222 OCD parent-child trios,
and it was further shown that these genes overlap with genes
previously implicated in TS10. Of note, Katayama et al. (2016)
demonstrated that mice heterozygous for Chd8 mutations manifest ASD-like behavioral characteristics including increased
anxiety, repetitive behavior, and altered social behavior11.
Using the Swedish National Registry, it was shown that
maternal polycystic ovary syndrome (PCOS), as a model for
investigating the role of prenatal androgen exposure, is a risk
for TS, ADHD and ASD12. These results support a potential
causal influence of prenatal androgen exposure on the development of male-predominant neuropsychiatric disorders in
female offspring of women with PCOS.
Still in Sweden, Brander et al.13 investigated whether, at the
population level, tic-related OCD has a stronger familial load
than non-tic-related OCD. They found that the risk of OCD in
relatives of individuals with tic-related OCD was considerably greater than the risk of OCD in relatives of individuals with
non-tic-related OCD, concluding that tic-related OCD is a
particularly familial subtype of OCD. The results have important
implications for ongoing gene-searching efforts.
Environmental risk factors. The EMTICS study was a large
European multicenter trial investigating, among several subjects,
the role of immunology in the etiology of tics, a long-discussed
hypothesis in the context of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) / Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections
(PANDAS). A first paper on neuronal surface proteins on 188
patients with TS failed to confirm a link between pathogenic
antibodies and causation of tics14. In line with these findings,
Baumgaertel et al.15 failed to detect autoantibodies in the
CSF of 20 adult patients with TS. However, 20% of these
patients had positive oligoclonal bands, an intriguing
finding with no clear-cut explanation to date. Also, in the
neuroimmunological field, Gilbert provides a thoughtful review of
the PANDAS/PANS controversy16.
Chen et al.17, using the National Health Insurance Research
Database of Taiwan, analyzed 2261 TS patients and 20349
non-TS controls for the risk of traumatic brain injury (TBI). During
follow-up, there was a significantly increased risk for TBI
in TS patients compared to controls. Classic comorbidities such
as ADHD, OCD and depression increased the risk for TBI,
whereas the regular use of antipsychotic medication decreased
it. These findings have important therapeutic implications,
as it underlines the need to offer proper and sustained anti-tic
treatment in patients, even if these treatments may be sedative,
as may be the case for antipsychotics.

Pathophysiology
Singer and Augustine have published two excellent and
exhaustive reviews on the pathophysiology of tics/TS (including
controversies) and the relevance for pharmacotherapy18,19.

Electrophysiology. Loo et al.20 performed a 128-channel
electroencephalogram (EEG) study on children with TS during
an exaggerated blink task and showed overall higher gamma
band spectral power and differences in theta, alpha, and beta
band power in inferior parietal cortex in TS children compared
to controls.
Niccolai et al.21 studied motor-related beta oscillations in TS
using magnetoencephalography and showed a biphasic increasedecrease pattern of beta oscillations. The decrease of beta
oscillations was observed close to tic execution, similarly to
what was observed in voluntary actions. The initial increase
in beta power positively correlated with premonitory urges.
Similarly, Zaparolli et al.22 studied the neural activity over
the sensorimotor cortex using EEG during a finger movement task in TS and found decreased levels of beta modulation
compared to controls in tic-free conditions. However, the abnormal pattern normalized if the patients were actively suppressing
tics during the task.
Zhu et al.23 recorded local field potentials in the globus
pallidus internus (GPi) and sub-thalamic nucleus (STN) of patients
with TS and found that beta and gamma oscillations in the GPi
were restored after deep brain stimulation (DBS) of the GPi
but not after DBS of the STN, suggesting that these oscillations
may play a role in pathophysiology of persistent tics. Another
study using microelectrode recordings of the STN during
DBS surgery in a single TS patient was able to identify a
single unit activity of the STN within the delta band, which was
reliably associated to optimal DBS target site for tic control24.
Neuroimaging studies. Ramkiran et al.25 used graph theoretical
measures applied to resting-state functional magnetic resonance
imaging (fMRI) in adults with TS and studied functional properties of different portions of cortico-basal ganglia-cerebellar
networks. They showed increased basal ganglia-cortical and
thalamo-cortical connectivity but reduced cortico-cerebellar
connectivity compared to controls. The authors also reported
reductions in serial information transfer within the default
mode and the salience functional networks. Altogether, the
findings suggested disruption of interoceptive mechanisms
and of brain maturation, as well as a shift towards excitatory
neurotransmission in TS.
Sigurdson et al.26 focussed on cerebellar morphology and
structural connectivity (structural co-variance) in TS and
found reduced grey matter volumes in part of the cerebellum
involved in motor and cognitive information processing compared top controls. The cerebellum also had abnormal structural
connectivity with sensori-motor networks and fontal and cingulate cortices. These findings highlight the importance of the
cerebellum in tic pathophysiology. The same approach of structural co-variance was used to study the structural underpinnings
of premonitory urges with a specific focus on the right insula27.
The severity of tics and premonitory urges correlated, respectively, with posterior (representing the current physiological
state) and anterior (associated with urges for action) sub-regions
of the insula. In addition, these sub-regions of insular cortex
were related to different structural networks, suggesting that
separate networks support tics and premonitory urges in TS.
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In one of the largest to date studies on resting state functional
connectivity in adults and children with TS, Neilson et al.28
showed that patterns of functional connections alterations
were age-dependent: while brain networks in TS children presented features of older age, adult TS brain networks appeared
“younger” in comparison to age-matched controls. Overall, these
findings underline the differences in TS neurodevelopmental
trajectories.
Finally, O’Neil et al. wrote a comprehensive review about
neuroimaging findings on the role of the cingulate cortex in
TS, suggesting that at least six to eight different sub-regions
of this cortical area might be implicated in different aspects
of TS pathophysiology, and are especially involved with premonitory urges29. Activity in the subgenual and pregenual
anterior cingulate as well as in the middle cingulate cortex
might represent volitional effort, physical discomfort and
emotional distress of premonitory urges; the posterior middle
cingulate cortex and dorsal posterior cingulate cortex might
play a role in amplification (build-up) of urges.
A positron emission tomography study of 33 adults found
that serotonin transporter (SERT) binding in caudate and
midbrain was normal in people with tics only or OCD only, but
was elevated in people with both tics and OCD30. This result,
if replicated, may suggest a nosological distinction between
TS with vs. without OCD, which would be surprising from a
clinical viewpoint.
Clinical and neuropsychological studies. Recent studies
indicate that the coordination of bimanual movements may
involve a number of brain areas: primary sensorimotor cortex,
supplementary motor area (SMA), premotor cortex, cingulate
motor cortex, lateral premotor cortex, basal ganglia, inferior
parietal cortex, and the cerebellum (many of which, incidentally, have been reported to be altered with respect to structure
and/or function in brain imaging studies of TS). However, it
is accepted that interhemispheric transfer is mediated through
excitatory and inhibitory transcallosal communications between
cortical motor areas and that the corpus callosum therefore
plays a major role in the coordination of bimanual movements, particularly asymmetric bimanual movements. A recent
study investigated externally paced (cued) and internally paced
bimanual tapping in adults with and without TS. Importantly, this study combined behavioral measures of bimanual
tapping with MRI-based diffusion tensor imaging and probabi
listic tractography of inter-hemispheric callosal connections
between the SMA and the left SMA–putamen fiber tract31. TS
patients were significantly less accurate than healthy individuals when asked to maintain a previously copied rhythmic
tapping speed at time intervals < 1 Hz32. Unimanual tapping is
the condition requiring the greatest level of interhemispheric
inhibition. TS patients also showed altered fractional anisotropy
in interhemispheric (SMA–SMA) and left-sided SMA–putamen
fiber tracts. These findings are consistent with compensatory
processes linked to self-regulation of motor control that may
occur through the plastic rearrangement of interhemispheric
and cortical-subcortical WM pathways.

Maigaard and colleagues studied the ability of children with
TS to suppress quick but inappropriate rewards33. Not
surprisingly, children with ADHD did poorly on this task,
but children with TS actually did better than healthy control
children. All groups improved their accuracy when a reward
was promised for accuracy. One hypothesis to explain these
results may be that children with TS have better motor inhibition in certain tasks due to their experience withholding tics
in response to premonitory urges due to social pressures. The
reward effect may correspond to the known improvement in tic
suppression in the presence of immediate rewards5,34.

Treatment
Psychological interventions. In a large study of manualized
CBT in children with OCD, anxious and depressive symptoms
improved substantially and were not linked to improvements
in OCD severity35. This result is one more argument in favor
of psychotherapy for obsessions and compulsions, which are
common in people with tics. A consensus report argues strongly
for early intervention in OCD36. Since early-onset OCD is associated with tics37, a similar argument could be made for early
intervention in tic disorders, especially since effective behavioral treatments without side effects are available. Studies of
whether early intervention changes the course of tic disorders
are needed.
One of the most interesting possibilities in delivering behavior
therapy for tics has come from the development of internetbased platforms, making these approaches available for a large
number of patients, even in remote areas. The BIP-TIC platform, developed in Sweden, allows to use either habit reversal
training (HRT), exposure response prevention (ERP) or a mixture
of both online with a possible intervention of a therapist by
phone or email. A first pilot study on 23 patients has shown
encouraging results in a rater-blind parallel group trial (including a 12 month follow up)38. A large (n= +200) UK-based study
of ERP using this platform, called ORBIT, will commence
shortly39.
Another way to increase the number of patients to be reached
by CBT is group therapy. A Danish study, using a combined
HRT/ERP approach has demonstrated that it is equally effective
in a group as in an individual setting with 27 patients per
treatment arm40. This represents a promising and interesting way
forward in CBT for tics.
Medication. The American Academy of Neurology (AAN)
practice guidelines for TS41,42 are one of the most important
publications in our field for 2019. A detailed analysis goes
way beyond the scope of this review but it might be worth
noting that the only “high confidence in the evidence” rating
was awarded to Comprehensive Behavioral Intervention for
Tics (CBIT) and not pharmacological or surgical therapies for
tics. This represents a true paradigm shift in the field. Similar
conclusions were drawn in another review of evidence-based
treatments for TS and CTD32.
In recent years, cannabis and cannabis-derived products are
being considered for the treatment of tics – and a variety of
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other movement disorders. Milosev et al.43 present results from a
retrospective data analysis and an online survey on the use
of cannabis-based medicine for tics and comorbidities in TS.
Patients (n= 98 and 40) expressed a preference for medical
cannabis (rich in THC) over dronabinol and nabiximols.
However, results from large randomized trials are still awaited
and will help guide therapeutic decisions. These will also
depend, obviously, on the availability of different cannabis-based
medications across countries.
Neurosurgery. Blocking tics by behavior therapy or botulinum
toxin has been hypothesized to interrupt the sensory-motor
feedforward loop likely operating in TS, i.e. premonitory
sensations triggering tics which then re-inforce premonitory
sensations. Kimura et al.44 report on four patients who had
undergone thalamic DBS for severe TS. In two, DBS could
be completely withdrawn four and seven years after surgery,
respectively, without re-increase in tics. This is intriguing
and confirms unpublished reports from other centers, including
our own (Paris). The authors raise the question of whether
some of the tics observed pre-op were functional tics. Alternatively, perhaps some patients with severe tics may need
treatment only for several years during development, when tics
may have been most severe without treatment. On the topic of
functional tics, which are occasionally seen by movement
disorder specialists, Ganos et al.45 have published a landmark
review which should be compulsory reading in the field.
In a 48 month follow-up of a multicentre trial comprising
16 severe TS patients treated with DBS of the anterior
pallidum, it was found that 75% of subjects were treatment
responders, that YGTSS (-40%) and global functioning scores
decreased significantly, and that self-injurious behaviors
ceased in all affected (n=7) patients46. Also, no persistent
psychiatric or neurological side effects were noted. However,
DBS did not lead to overall decrease in medication. Predictors
of long-term outcome for DBS in TS are still needed

and larger, perhaps international studies will be able to fill
that gap. One step towards that was signalled by a report of
initial results from an international TS-DBS registry relating
DBS active contact location to outcomes47.
Other treatments. Regarding unusual treatment methods
for tics, Murakami et al.48 describe the use of oral splints in
22 patients with TS. Tic decrease was noted in the vast majority
of cases and occurred almost instantaneously. The authors
suggest a placebo effect and/or a sensory trick as mechanism
of action. The major question here remains how and if such an
intervention can work long term and without impairing daily
functioning, especially speech.
A pilot study evaluated the efficacy of a resource activation
program as an alternative intervention for children and adolescents (n=24) with tic disorders49. Their preliminary results
suggest that after 16 treatment sessions, tics were significantly
diminished using the YGTSS and other tic-related measures.
Larger cohorts and longer follow-up will hopefully establish
whether this approach might become an alternative or adjunct
to established CBT approaches for treating tics such as HRT
and ERP.

Conclusions

They are the same as last year (and likely for a while to come)
but worth reiterating, and consist of several simple but
important questions: Why do tics tend to start at ages 5–10?
Why are they more common in boys? Why do they tend to
improve during sleep? Why do tics usually improve in early
adulthood? How accurately can we predict outcome for
an individual patient? Which patients need which treatments?
Is secondary prevention possible? Hopefully future studies
will address these and other important issues.

Data availability

No data are associated with this article.
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